January 11, 2017
Pharmaceutical giant Sanofi unlawfully claimed it had additional patents covering one of its diabetes drugs in a bid to stave off new competition, according to a proposed class action a Puerto Rico-based drug wholesaler filed in Massachusetts federal court Tuesday.